반응식
[CH3:1][CH:2]1[S:7][C:6](=[O:8])[NH:5][N:4]=[C:3]1[C:9]1[CH:10]=[C:11]2[C:15](=[CH:16][CH:17]=1)[NH:14][C:13](=[O:18])[C:12]2=[N:19]C1C=CC=CC=1.[N:26]1[CH:31]=[CH:30][CH:29]=[C:28]([NH:32]N)[CH:27]=1>>[N:26]1[CH:31]=[CH:30][CH:29]=[C:28]([NH:32][N:19]=[C:12]2[C:11]3[C:15](=[CH:16][CH:17]=[C:9]([C:3]4[CH:2]([CH3:1])[S:7][C:6](=[O:8])[NH:5][N:4]=4)[CH:10]=3)[NH:14][C:13]2=[O:18])[CH:27]=1참가 물질
3
실험 절차
Starting from 1,3-dihydro-5-(3,6-dihydro-6-methyl-2-oxo -2H-1,3,4-thiadiazin-5-yl)-3-phenylimino-2H-indol-2-one, and 3-pyridylhydrazine and following the method described in Example 21, the desired compound was obtained.
출처 및 근거
- ORD 기록
- ord-2a88f94d4d0b4e988a6a220261901bc9
- 출처 데이터셋
- uspto-grants-1991_09
- 특허 번호
- US05051417
연결된 노트
불러오는 중…